Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2024-05-29 Proxy Solicitation & In…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
PROPOSED ISSUANCE OF A SHARES AND NOTICE OF EGM
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from the Board of RemeGen Co., Ltd. regarding a proposed issuance of A shares and notice of an Extraordinary General Meeting (EGM). It includes detailed information about the issuance plan, feasibility reports, use of proceeds, dilution effects, dividend plans, and the notice of the EGM itself. The document is comprehensive and intended to inform shareholders to make decisions at the EGM. It is not a simple announcement but a detailed circular with multiple appendices and formal proposals. This type of document is best classified as a Proxy Solicitation & Information Statement (PSI), as it provides information and requests votes for the meeting. It is not an Annual Report, Earnings Release, or Capital/Financing Update alone, but a solicitation document for shareholder approval of a capital issuance and related matters.
2024-05-29 English
Documents on Display
Report Publication Announcement Classification · 95% confidence The document is a short announcement from the HKEX website regarding 'ADJUSTMENT TO THE AMOUNTS OF THE EXPECTED DAY-TO-DAY RELATED (CONNECTED) TRANSACTIONS' for RemeGen Co., Ltd. It provides links to several underlying documents (agreements, letters of recommendation, etc.) rather than being the full report itself. Following the 'Menu vs Meal' rule, this is a notification of the publication of these documents, making it a Report Publication Announcement (RPA).
2024-05-28 English
PROXY FORM FOR USE AT THE 2023 ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a proxy form for the 2023 Annual General Meeting (AGM) of RemeGen Co., Ltd. It includes instructions for shareholders to appoint proxies to vote on various resolutions at the AGM, including approval of the annual report, financial accounts, profit distribution plan, re-appointment of accounting firms, remuneration of directors and supervisors, share issuance mandates, amendments to articles of association, and internal management policies. The content is focused on voting procedures and resolutions to be considered at the AGM rather than the full annual report or financial statements themselves. The document length is 7989 characters, which is consistent with a detailed proxy form but not a full report. Therefore, this document is best classified as AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms and voting materials.
2024-05-28 English
NOTICE OF 2023 ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the 2023 Annual General Meeting (AGM) for RemeGen Co., Ltd. It includes details about the date, location, agenda items such as approval of the annual report, financial accounts, profit distribution plan, re-appointment of accounting firms, and other resolutions to be considered at the AGM. The document is a formal announcement inviting shareholders to attend and vote at the AGM, not the actual annual report or financial statements themselves. The length is 6317 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2024-05-28 English
2023 ANNUAL GENERAL MEETING CIRCULAR
AGM Information Classification · 95% confidence The document is a circular related to the 2023 Annual General Meeting (AGM) of RemeGen Co., Ltd. It includes the Notice of the AGM, details of proposed resolutions to be voted on at the AGM, and references to various reports such as the 2023 Report on the Work of the Board of Directors, the 2023 Report on the Work of the Supervisory Committee, the 2023 Financial Accounts Report, and the 2023 Annual Report and Accounts. The document also contains a proxy form and instructions for shareholders to vote. The content is typical of materials distributed to shareholders ahead of an AGM to inform them and solicit their votes. It is not the annual report itself, nor a financial statement, but rather the circular and notice for the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content support this classification with high confidence.
2024-05-28 English
CLOSURE OF REGISTER OF MEMBERS FOR 2024 FIRST EXTRAORDINARY GENERAL MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from RemeGen Co., Ltd. regarding the closure of the register of members for the 2024 first extraordinary general meeting (EGM). It specifies the dates for the register closure and eligibility for voting at the EGM. There is no financial data, report content, or detailed meeting materials included. The document is short (2465 characters) and serves as a notice related to shareholder meeting logistics rather than the meeting itself or voting results. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories like DVA (voting results) or PSI (proxy solicitation).
2024-05-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.